Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
AstraZeneca
Medtronic
Boehringer Ingelheim
McKesson

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

FABRAZYME Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: FABRAZYME
Pharmacology for FABRAZYME
Ingredient-typealpha-Glucosidases

US Patents for FABRAZYME

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24   See Pricing Orphazyme ApS (Kobenhavn N, DK) 2028-06-26 RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24   See Pricing Protalix Ltd. (Carmiel, IL) 2029-11-17 RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24   See Pricing SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24   See Pricing SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for FABRAZYME

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013/054 Ireland   See Pricing PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
CR 2013 00060 Denmark   See Pricing PRODUCT NAME: AGALSIDASE BETA; REG. NO/DATE: EU/1/01/188/001-003 20010803
C02210947/01 Switzerland   See Pricing PRODUCT NAME: AGALSIDASE BETA; NAT. REGISTRATION NO/DATE: SWISSMEDIC 56261 20030725
C300627 Netherlands   See Pricing PRODUCT NAME: METHOD FOR PRODUCING SECRETED PROTIENS; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
McKinsey
Harvard Business School
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.